ARCHIVES

Also in this 8-page issue: Richard Pazdur named director of FDA’s new Office of Oncology Drug Products.

This article is from The Cancer Letter archive.

Vol. 31 No. 16 | April 22, 2005

Download PDF Visit The Full Archive

Related Articles

UPCI To Lead Clinical Trials Of Eli Lilly’s Oncology Agents.

July 6, 2001

In Brief: Gene Therapy Pioneer Michael Blaese To Leave NIH For Biotechnology Firm

January 23, 1998

House Bill, Report Do Not Include Any Earmarks Or Directives To Aid CCOP, Centers, Cancer Control

August 7, 1987

Study Reveals Racial Disparities In Surgical Prostate Care

August 31, 2012

Roferon A Application Marred By Mission Data, Protocol, Compliance

September 24, 1999

Cancer Registry Says Paper By Jon Sudbo Was Based On Fabricated Data.

January 27, 2006